IMS Health (RX) Down On Reports Senate Moving to Block Drugmakers from Mining Rx Data
Tweet
Share
E-mail
IMS Health Inc. (NYSE: RX) is under pressure on reports the Seante has moved to block drugmakers from using prescription records to pitch doctors. Shares are down 15% to $18.19.
NOTE: IMS Health has a deal to be acquired for $22 per share in cash. by TPG Capital and the CPP Investment Board
NOTE: IMS Health has a deal to be acquired for $22 per share in cash. by TPG Capital and the CPP Investment Board
You May Also Be Interested In
- Reddit (RDDT) added to S&P 500
- BioSyent Schedules Q2 and H1 2026 Earnings Release for August 20, 2026
- Avalonbay Communities (AVB) dropped from S&P 500
Create E-mail Alert Related Categories
Insiders' Blog, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
